MET and pancreatic neoplasm: The HGF/c-MET (mesenchymal–epithelial transition factor) pathway is emerging as a key area of focus in understanding and potentially disrupting the intricate cellular interaction that results in pancreatic cancer’s aggressiveness and resistance to treatment.